What do you get when a $14,000-a-year med you’re selling is exposed for NOT saving lives?
I’d like to think that you’d get laughed right out of medicine.
In reality, you could get a big-time upgrade!
At this very moment, while you’re enjoying the middle of summer, mainstream medical authorities are conspiring behind closed doors to give a sloppy, wet kiss to one of their Big Pharma pals.
The American College of Cardiology is working on new guidelines to EXPAND the use of an expensive and controversial cholesterol drug.
And despite an incredible price tag of more than $500 a pop for shots delivered twice a month, the drug is proven to save exactly ZERO lives!
The drug is called evolocumab, a PCSK9 inhibitor that can slash LDL cholesterol by 59 percent.
Those are levels so low, you could win a “patient of the month” award at your doctor’s office!
But that’s about all you’ll get… because studies show this drug and its super-low LDL levels won’t extend your life by so much as a single second.
You won’t hear that from your doctor, of course.
He’ll whip out a study that claims it cuts the risk of cardiovascular death, heart attack, stroke, hospitalization for unstable angina, and coronary revascularization.
But they pulled an ugly little trick to make that claim.
All of those risks were lumped into a single category… like putting Jack Harrison and Hank Aaron into a “group” and then saying this “group” hit a combined 755 Major League home runs.
Just like we all know that ol’ Jack didn’t hit a single one of those dingers, the numbers in the studies show that the drug didn’t cut the risk of cardiovascular death or death from any other cause.
The best you can say about the thing is that it might cut the risk of nonfatal heart attacks… but even then, it’s nothing to write home about.
The ABSOLUTE reduction in the risk of a heart attack was just 1.2 percent, along with a 1.5 percent drop in the need for a bypass and a 0.4 percent cut in the risk of a stroke.
Those numbers are so small that you need to break out a magnifying glass to see them!
In real terms, those numbers mean you’d have to treat 74 patients for two years — at a combined cost of more than $2 million — to prevent a single event like a heart attack.
That’s insane, especially when you consider that you don’t take this drug INSTEAD of a statin. You take it WITH a statin, meaning all the usual risks and side effects apply: muscle pain, sexual dysfunction, memory loss, diabetes, and more.
It’s time for a new and SANE approach instead. Work closely with a doc who knows what you really need to worry about — such as inflammation — instead of obsessing over LDL charts and pushing overpriced meds.